1351237-75-6

Upstream product

• 1351238-58-8 methyl 5-(2,4-dimethoxybenzylamino)-4-nitrothiophene-2-carboxylate 
• 1351238-59-9 methyl 5-(tert-butoxycarbonylamino)-4-nitrothiophene-2-carboxylate 
• 1351238-63-5 methyl 5-(tert-butoxycarbonylamino)-4-(2-methoxy-2-oxoethylamino)thiophene-2-carboxylate 
• 1351238-60-2 methyl 4-amino-5-(tert-butoxycarbonylamino)thiophene-2-carboxylate 
• 1351238-66-8 methyl 3-oxo-3,4-dihydrothieno[2,3-b]pyrazine-6-carboxylate 
• 1351238-67-9 methyl 3-chlorothieno[2,3-b]pyrazine-6-carboxylate 
• 1351238-68-0 3-chlorothieno[2,3-b]pyrazine-6-carboxylic acid 
• 1351238-69-1 3-chlorothieno[2,3-b]pyrazine-6-carbonyl chloride 
• 119-32-4 4-Methyl-3-nitroanilin 
• 1351238-70-4 3-chloro-N-(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methylphenyl)thieno[2,3-b]pyrazine-6-carboxamide 
• 74-89-5 methylamine 
• 57800-76-7 5-chloro-4-nitrothiophene-2-carboxylic acid methyl ester 
• 872090-71-6 N-(3-amino-4-methylphenyl)-3-(2-cyanopropan-2-yl)benzamide 
• 872091-00-4 3-(1-cyano-1-methylethyl)benzoic acid 

Relevant academic research and scientific papers

THIENO (2, 3B) PYRAZINE COMPOUNDS AS B-RAF INHIBITORS

The invention relates to compounds according to general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of cancer.

THIENO (2, 3B) PYRAZINE COMPOUNDS AS B - RAF INHIBITORS

The invention relates to compounds according to general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of cancer.